SPECIALTY TOPICS · GUIDE
Adjacent Research Map: Longevity, Biohacking and Emerging Wellness Science
A guide to where peptide-adjacent topics are covered on this site: aging research, biohacking, consumer devices, and cell, gene and molecular therapies.
Content last updated . This page has not been medically reviewed.
Back to Peptides & Modern ResearchWhy a map
Peptide advertising often borrows from neighboring fields: aging, biohacking, wearables, stem cells, gene therapy. Those topics have their own guides on this site, written for their own evidence. This page does not repeat them. It points to the right home so you can see each claim in its proper context. The name of a field tells you little about whether a specific product works. Every topic is judged on its own evidence.Evidence labels used here
Across the library we use plain labels: approved medicine, established, promising but limited, mixed, insufficient evidence, preclinical (cells or animals only), no good evidence of benefit, evidence of harm and marketing claim. How we apply them is explained in how we label evidence in Specialty Topics.Where each topic lives
Three things that help in every neighboring field
Check the regulatory status of the exact product. The U.S. FDA publishes a list of licensed cellular and gene therapy products. [1] It also warns that unapproved products marketed as regenerative include stem cells, exosomes and other materials, and that a ClinicalTrials.gov listing does not make a product legally marketed. [2] Rules differ by country, so a statement about one country is not a statement about another.Do not carry results across. Peptide drugs and antibodies, for instance, are different families. One review compares peptides with small molecules and biologics and lists distinct strengths and limits for each. [3] A result for one class says little about another. In the same way, a promising laboratory method is a step on the way, not an outcome. See reading early-stage research.
Ask what was measured. A biomarker or a score from a device is not the same as feeling better or living longer. See biomarkers and biological age tests. Peptide-specific study types are described in the peptide research landscape.
Frequently asked questions
Is longevity research the same as peptide research?
No. They overlap only where particular peptides are studied or marketed for aging, and those claims are reviewed separately. See peptides and aging claims.
Are stem cell and gene therapies the same thing?
No. They are different technologies. FDA describes gene therapy as modifying a person's genes or the biological properties of living cells for therapeutic use. [4] Stem cell products are cell-based, and its regenerative medicine page (content current as of April 2024) lists only blood-forming cord blood cells as approved stem cell products. [2]
Where do I find the full coverage of emerging technologies?
In Emerging Wellness Science, which this library links to rather than duplicates.
Does a wearable or lab test tell me if a peptide works?
Not by itself. A tracked number is a measurement, and the question is whether it reflects a real health outcome. See wearables and health trackers.
Why does this library keep sending me to other sections?
Each topic has one home so the evidence stays accurate and is not repeated in slightly different forms.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Safety note
References
- U.S. Food and Drug Administration. Approved Cellular and Gene Therapy Products. Read 2026-10-22.
- U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies (content current as of 04/08/2024). Read 2026-10-22.
- Wang L, Wang N, Zhang W et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther 2022. PubMed. Read 2026-10-22.
- U.S. Food and Drug Administration. What is Gene Therapy? Read 2026-10-22.